The aim of this study was to determine if long-term treatment with melatonin (MEL), a purported anti-aging agent, was as effective as calorie restriction (CR) in modulating immune parameters in aging Fischer 344 male rats. Splenic lymphocytes were isolated from 17-month-old rats that, beginning at 6 weeks of age, were treated with MEL (4 or 16 μg/ml in drinking water) and from 17-month-old rats fed ad libitum (AL) or rats fed a CR diet (55% of AL intake). The number of splenic T cell populations and T cell subsets was measured by flow cytometry, the proliferative response of splenocytes to Concanavalin A (Con A) and lipopolysaccharide (LPS) was measured by [3H]thymidine incorporation, and the induction of cytokine production (IL-2 and IFN-γ) was measured by ELISA assay. In addition, the level of the natural killer (NK) cell activity was assessed by fluorimetric assay. CR rats had a higher number of lymphocytes expressing the naïve T cell marker (CD3 OX22) than AL rats (P < 0.05). CR rats also showed greater induction of proliferative response, IL-2 and IFN-γ levels following Con A simulation, and NK cell activity than AL rats (P < 0.05). MEL-treated rats did not differ from AL rats in any of these parameters or in any other measurement. These results indicate that MEL treatment is unable to modulate immune function in a manner comparable with that of CR.
MaestroniGJ, ContiA, LissoniP.Colony-stimulating activity and hematopoieticrescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res54: 4740–4743, 1994.
2.
Molina-CarballoA, Munoz-HoyosA, ReiterRJ, Sanchez-ForteM, Moreno-MadridF, Rufo-CamposM.Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years experience. J Pineal Res23: 97–105, 1997.
3.
ReiterRJ, ReiterMN, HattoriA, YagaK, HerbertDC, Barlow-WaldenL.The pinealmelatonin rhythm and its regulation by light in a subterranean rodent, the valley pocket gopher (Thomomys bottae). J Pineal Res16: 145–153, 1994.
4.
KotlerM, RodriguezC, SainzRM, AntolinI, Menendez-PelaezA.Melatoninincreases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res24: 83–89, 1998.
MayoJC, SainzRM, UriaH, AntolinI, EstebanMM, RodriguezC.Inhibition of cellproliferation: a mechanism likely to mediate the prevention of neuronal cell death bymelatonin. J Pineal Res25: 12–18, 1998.
7.
ContiA, MaestroniGJ. The clinical neuroimmunotherapeutic role of melatonin inoncology. J Pineal Res19: 103–110, 1995.
8.
MaestroniGJ, ContiA, PierpaoliW.Role of the pineal gland in immunity: circadiansynthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol13: 19–30, 1986.
9.
MaestroniGJ, ContiA, PierpaoliW.Role of the pineal gland in immunity: II. Melatoninenhances the antibody response via an opiatergic mechanism. Clin Exp Immunol68: 384–391, 1987.
10.
MaestroniGJ. The immunoneuroendocrine role of melatonin. J Pineal Res14: 1–10, 1993.
11.
ReiterRJ. Oxidative processes and antioxidative defense mechanisms in the agingbrain. FASEB J9: 526–533, 1995.
12.
ReiterRJ, TanDX, PoeggelerB, Menendez-PelaezA, ChenLD, SaarelaS.Melatonin as a free radical scavenger: implications for aging and age-relateddiseases. Ann N Y Acad Sci719: 1–12, 1994.
13.
GiladE, CuzzocreaS, ZingarelliB, SalzmanAL, SzaboC.Melatonin is a scavenger of peroxynitrite. Life Sci60: L169–L174, 1997.
14.
PierpaoliW, RegelsonW.Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci U S A91: 787–791, 1994.
15.
Oaknin-BendahanS, AnisY, NirI, ZisapelN.Effects of long-term administration of melatonin and a putative antagonist on the ageing rat. Neurol Rep6: 785–788, 1995.
16.
CaroleoMC, DoriaG, NisticoG.Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann NY Acad Sci719: 343–352, 1994.
17.
MocchegianiE, BulianD, SantarelliL, TibaldiA, MuzzioliM, PierpaoliW, FabrisN.The immunoreconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol53: 189–201, 1994.
18.
AngeliA, GattiG, SartoriML, Del PonteD, CerignolaR.Effect of exogenous melatonin on human natural killer (NK) cell activity. An approach to the immunomodulatory role of the pineal gland. In: GuptaD, AttanasioA, ReiterRJ Eds. The Pineal Gland and Cancer. Tübingen, Müller and Bass, pp 145–156, 1988.
19.
PioliC, CaroleoMC, NisticoG, DoriaG.Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol15: 463–468, 1993.
20.
MaestroniGJ, ContiA, PierpaoliW.Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology63: 465–469, 1988.
21.
PawlikowskiM, LysonK, Kunert-RadekJ, StepienH.Effect of benzodiazepines on the proliferation of mouse spleen lymphocytes in vitro. J Neural Transm73: 161–166, 1988.
22.
ProvincialiM, Di StefanoG, BulianD, StronatiS, FabrisN.Long-term melatonin supplementation does not recover the impairment of natural killer cell activity and lymphocyte proliferation in aging mice. Life Sci61: 857–864, 1997.
23.
PahlavaniMA, HarrisMD. In vitro effects of melatonin on mitogen-induced lymphocyte proliferation and cytokine expression in young and old rats. Immunopharmacol Immunotoxicol19: 327–337, 1997.
24.
ArztES, Fernandez-CasteloS, FinocchiaroLM, CriscuoloME, DiazA, FinkielmanS, NahmodVE. Immunomodulation by indoleamines: serotonin and melatonin action on DNA and interferon-γ synthesis by human peripheral blood mononuclear cells. J Clin Immunol8: 513–520, 1988.
25.
MasoroEJ, McCarterRM. Dietary restriction as a probe of mechanisms of senescence. Ann Rev Gerontol10: 183–197, 1990.
PahlavaniMA. Does caloric restriction alter IL-2 transcription?Front Biosci3: d125–d135, 1998.
29.
WeindruchR, GottesmanSR, WalfordRL. Modification of age-related immune decline in mice dietarily restricted from or after midadulthood. Proc Natl Acad Sci U S A79: 898–902, 1982.
30.
WeindruchR, DevensBH, RaffHV, WalfordRL. Influence of dietary restriction and aging on natural killer cell activity in mice. J Immunol130: 993–996, 1983.
31.
SandykR.Melatonin supplements for aging. Int J Neurosci87: 219–224, 1996.
32.
PahlavaniMA, RichardsonA.Age-related decrease in the naive (OX22+) T cells in F344 rats. Mech Ageing Dev74: 171–176, 1994.
33.
McCarthyKF, HaleML, FehnelPL. Rat colony-forming unit spleen is OX7 positive, W3/13 positive, OX1 positive, and OX22 negative. Exp Hematol13: 847–854, 1985.
34.
PahlavaniMA, CheungTH, CheskyJA, RichardsonA.Influence of exercise on the immune function of rats of various ages. J Appl Physiol64: 1997–2001, 1988.
35.
ManfrediB, SacerdoteP, BianchiM, LocatelliL, Veljic-RadulovicJ, PaneraiAE. Evidence for an opioid inhibitory effect on T cell proliferation. J Neuroimmunol44: 43–48, 1993.
36.
PahlavaniMA, HarrisMD. Effect of dehydroepiandrosterone on mitogen-induced lymphocyte proliferation and cytokine production in young and old F344 rats. Immunol Lett47: 9–14, 1995.
37.
ProvincialiM, Di StefanoG, FabrisN.Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay. J Immunol Methods155: 19–24, 1992.
38.
PahlavaniMA. Caloric restriction and immunosenescence: a current perspective. Front Biosci5: D580–D587, 2000.
39.
VenkatramanJ, AttwoodVG, TurturroA, HartRW, FernandesG.Maintenance of virgin T cells and immune function by food restriction during aging in ling-lived B6D2F1 female mice. Aging Immunol Infec Dis5: 13–25, 1994.
40.
CristinaMC, DanielaF, GiuseppeN.Melatonin as immunomodulatory in immunodeficient mice. Immunopharmacology23: 81–89, 1992.
41.
LucasLC, Guan-JieC, MariaCL. Melatonin induced increase in γ-interferon production by murine splenocytes. Immunol Lett33: 123–126, 1992.
42.
KolitzJE, WelteK, SykoraKW, MertelsmannR.Interleukin 2: a review. Arzneimittelforschung35: 1607–1615, 1985.
43.
PatriniG, SacerdoteP, FuzioD, ManfrediB, ParolaroD.Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound. J Neuroimmunol80: 143–148, 1997.
44.
SzeSF, LiuWK, NgTB. Stimulation of murine splenocytes by melatonin and methoxytryptamine. J Neural Transm Gen Sect94: 115–126, 1993.
45.
AtreD, BlumenthalEJ. Melatonin: immune modulation of spleen cells in young, middle aged and senescent mice. Mech Ageing Dev103: 255–268, 1998.
